Oral Cancer and Prospects of Precision Medicine

Pp: 353-366 (14)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Precision medicine is a systematic therapeutic approach that tailors the overall treatment process as per an individual's unique characteristics; taking into account the genomic makeup and lifestyle. This approach has shown promising results in treating certain types of cancers, including that of highly heterogeneous oral cancer. Oral cancer is a type of head and neck cancer mainly caused by poor oral hygiene, alcohol, and tobacco abuse, and promotes HPV infection. The conventional approaches for the treatment of oral cancer often rely on surgery, chemotherapy, and/or radiotherapy. Now, precision medicine, with the advent of newer diagnostic techniques, enables healthcare professionals to diagnose the disease early and treat the patient with appropriate medicines and optimized doses. This ensures overall safety while minimizing undesirable exposure to not-so-effective drug regimes. After a brief introduction to precision medicine, this chapter details genetic mutations as targets for precision medicine and the advantages of this approach in oral cancer treatment. It is envisaged that this approach offers improved efficacy, safety, reduced side-effects, and prepares the body’s immune response against oral cancer. Targeting specific proteins, such as EGFR and HER2 to suppress tumor growth or make cancer cells more susceptible to the immune system’s combat mechanism is also discussed followed by an overview of various drugs that are being used to treat patients who are positive for HER2 and EGFR. Various challenges and limitations of precision medicine and future prospects for research in this area are highlighted.

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books